Rx/reimbursement adult incontinence recorded an upturn in demand over the course of 2021, driven by increasing price sensitivity as consumers looked to save money wherever possible, in addition to greater awareness of their entitlement to these products if they did have to enter hospital or other healthcare institutions during the pandemic. Many consumers tend to learn about their entitlement to free products when they visit a healthcare institution.
Domestic player Ontex Global is the main player within Rx/reimbursement adult incontinence, working closely with the government to supply these products. This player benefits from its strength in retail adult incontinence and away-from-home adult incontinence, while also being a private label supplier of these products.
The forecast period is set to see fairly stable demand for Rx/reimbursement adult incontinence products, supported by an ageing population and price sensitivity, remaining larger in overall size compared to retail adult incontinence in volume terms.
Over the forecast period, demand will continue to benefit from population ageing and from the fact that the government is keen to woo elderly voters, thus continuing to promote its allowance for incontinence sufferers. The government will continue to promote the social funding of adult incontinence purchases, encouraging many consumers who previously purchased retail adult incontinence to apply for an allocation.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Belgium with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Belgium, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See All of Our DefinitionsThis report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!